Risk factors

Community Healthcare Trust Inc relies heavily on rental revenue from 200 healthcare properties concentrated in Texas, Illinois, and Ohio. The company faces significant lease renewal pressure, with 68 leases expiring in 2025 and 72 in 2026. Growth depends on sourcing off-market deals and securing external capital amid strict REIT distribution rules.

Centene faces extensive government regulation and contracting risks across Medicaid, Medicare, and Marketplace insurance programs.

This company has no prior year risk disclosures on file.

ConocoPhillips faces dominant risks from commodity price volatility, reserve replacement challenges, and geopolitical uncertainties. Integration of the Marathon Oil acquisition and environmental compliance introduce significant additional operational complexities.

CenterSpace is concentrated in multifamily apartments across the Midwest and Mountain West, making occupancy, rents, and regional demand central risks.

CVRx faces continuous losses with an accumulated deficit of $537.3 million as of December 31, 2024. Commercial success relies heavily on marketing Barostim, securing hospital purchasing contracts, and Medicare reimbursement levels. Manufacturing depends on a single facility in Minneapolis, Minnesota, and limited third-party suppliers.

Geographic concentration in New England and Mid-Atlantic states exposes operations to regional weather, economic, and regulatory changes. Heavy debt load of $1,148.2 million restricts operational flexibility and future financing. Emerging PFAS regulations and EPA hazardous designations increase remediation and compliance costs. Dual-class stock structure grants Chairman and CEO John W. Casella disproportionate voting control.

Technology transitions, capital markets activity, and regulatory compliance heavily dominate the risk profile of Donnelley Financial Solutions.

Energy industry spending volatility and oil and gas price fluctuations heavily dictate customer demand and revenue. Steel price volatility and import tariff changes significantly impact product margins and cash flow. Extensive environmental, health, safety, and international regulations create substantial compliance and liability exposures.

Dexcom faces intense pricing pressure from managed care organizations and government health programs affecting core products like G6, G7, and Dexcom One. Strict regulatory oversight, manufacturing dependencies, cybersecurity demands, and rapid technological competition heavily dominate the company's risk profile.

Regulatory proceedings can delay rate changes and disallow utility costs, putting recovery of fuel, storm, and capital spending at risk.

Regulatory proceedings drive rate-setting and recovery of fuel, purchased-power, storm, and capital costs.